fda compounding semaglutide warning letters october 2025 Beyond the Headlines: to GLP-1 Compounders Troubling Findings in Study of

It enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system effects

Staying hydrated helps reduce potential side effects like headaches or fatigue

Theyre not licensed nationallythey employ providers with licenses in multiple states and match you to someone licensed where you are

Some benefits of FDA-approved GLP-1/GIP medications beyond weight loss are supported by emerging research and may vary based on individual health conditions, including: Improve blood sugar regulation, increase insulin sensitivity, and lower A1C Reduce long-term diabetic risks and protect pancreatic function Lower cholesterol, triglycerides, and blood pressure, supporting long-term cardiovascular health Show promising reductions in heart attacks and strokes in early studies Reduce liver fat and potentially improve metabolic fatty liver disease

J.MulpuriY.LeggioL.SpigelmanI